Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 3 (2007), Issue 5 (May)

1. Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.
   J Clin Oncol, 25(13): 1677-82. [Abstract] [Full-text]
2. Attenuation-corrected vs. nonattenuation-corrected 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in oncology: a systematic review.
   Mol Imaging Biol, 9(3): 99-105. [Abstract] [Full-text]
3. Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.
   J Thorac Oncol, 2(5): 440-4. [Abstract] [Full-text]
4. The art of pediatric oncology nursing practice.
   J Pediatr Oncol Nurs, 24(3): 132-8. [Abstract] [Full-text]
5. A Gynecologic Oncology Group study of platinum-DNA adducts and excision repair cross-complementation group 1 expression in optimal, stage III epithelial ovarian cancer treated with platinum-taxane chemotherapy.
   Cancer Res, 67(9): 4474-81. [Abstract] [Full-text]
6. Special issue of Psycho-Oncology on cancer genetic testing and psychosocial research.
   Psychooncology, 16(5): 504. [Abstract] [Full-text]
7. A practical approach to geriatric assessment in oncology.
   J Clin Oncol, 25(14): 1936-44. [Abstract] [Full-text]
8. Radiation therapy and the geriatric oncology patient.
   J Clin Oncol, 25(14): 1930-5. [Abstract] [Full-text]
9. Multidisciplinary approach to the geriatric oncology patient.
   J Clin Oncol, 25(14): 1876-81. [Abstract] [Full-text]
10. International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature.
    J Clin Oncol, 25(14): 1832-43. [Abstract] [Full-text]
11. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
    Expert Rev Mol Diagn, 7(3): 269-80. [Abstract] [Full-text]
12. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019.
    Cancer, 109(8): 1506-12. [Abstract] [Full-text]
13. Pitfalls in MR image interpretation prompting referrals to an orthopedic oncology clinic.
    Radiographics, 27(3): 805-26; discussion 827-8. [Abstract] [Full-text]
14. Monitoring diagnostic accuracy and complications. A report from the Children's Oncology Group Hodgkin lymphoma study.
    J Pediatr Surg, 42(5): 788-91. [Abstract] [Full-text]
15. Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study.
    Invest New Drugs, 25(3): 253-8. [Abstract] [Full-text]
16. Managing hematologic toxicities in the oncology patient.
    J Infus Nurs, 30(3): 168-72. [Abstract] [Full-text]
17. The impact of infusion reactions on oncology patients and clinicians in the inpatient and outpatient practice settings: oncology nurses' perspectives.
    J Infus Nurs, 30(3): 153-60. [Abstract] [Full-text]
18. Non-inferiority trials in surgical oncology.
    Ann Surg Oncol, 14(5): 1532-9. [Abstract] [Full-text]
19. The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG).
    Eur J Haematol, 78(6): 468-76. [Abstract] [Full-text]
20. The Health Utilities Index 3 invalidated when completed by nurses for pediatric oncology patients.
    Cancer Nurs, 30(3): 169-77. [Abstract] [Full-text]
21. Quality of life in long-term survivors of ovarian germ cell tumors: a Gynecologic Oncology Group study.
    Gynecol Oncol, 105(3): 687-94. [Abstract] [Full-text]
22. A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: a Gynecologic Oncology Group study.
    Gynecol Oncol, 105(3): 667-71. [Abstract] [Full-text]
23. Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study.
    J Clin Oncol, 25(15): 1986-92. [Abstract] [Full-text]
24. Criteria for optimizing prognostic risk groups in pediatric cancer: analysis of data from the Children's Oncology Group.
    J Clin Oncol, 25(15): 2070-7. [Abstract] [Full-text]
25. Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group.
    J Clin Oncol, 25(15): 2057-62. [Abstract] [Full-text]
26. Report from the 1st Japanese Urological Association-Japanese Society of Medical Oncology joint conference, 2006: 'A step towards better collaboration between urologists and medical oncologists'.
    Int J Urol, 14(5): 375-83. [Abstract] [Full-text]
27. Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group.
    J Cancer Res Clin Oncol, 133(7): 437-44. [Abstract] [Full-text]
28. Nutritional intervention and quality of life in adult oncology patients.
    Clin Nutr, 26(3): 289-301. [Abstract] [Full-text]
29. The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology.
    Cancer Treat Rev, 33(4): 369-80. [Abstract] [Full-text]
30. Diffusion-weighted MRI in the body: applications and challenges in oncology.
    AJR Am J Roentgenol, 188(6): 1622-35. [Abstract] [Full-text]
31. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
    Pediatr Blood Cancer, 49(1): 17-22. [Abstract] [Full-text]
32. A stress echocardiography study of cardiac function during progressive exercise in pediatric oncology patients treated with anthracyclines.
    Pediatr Blood Cancer, 49(1): 56-64. [Abstract] [Full-text]
33. Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses.
    Cancer Treat Rev, 33(3): 230-83. [Abstract] [Full-text]
34. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.
    Am J Surg Pathol, 31(6): 895-901. [Abstract] [Full-text]
35. The problems and promise of central pathology review: development of a standardized procedure for the Children's Oncology Group.
    Pediatr Dev Pathol, 10(3): 199-207. [Abstract] [Full-text]
36. Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.
    J Clin Oncol, 25(16): 2212-7. [Abstract] [Full-text]
37. Conducting end-of-life studies in pediatric oncology.
    West J Nurs Res, 29(4): 448-65. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.